1-3 of 3
glucosylceramide synthase inhibitors
Close
Save search
Sort by
Journal Articles

Effect of PDMP, a Glucosylceramide Synthase Inhibitor, On Resistance to Daunorubicin in Human Leukemia Cell Line K562/A02.

Free
Bao-An Chen, Li Yin, Jian Cheng, Jia-hua Ding, Chong Gao, Gang Zhao, Jun Wang, Guo-hua Xia, Ning-Na Chen, Xiao-Ping Pei
Journal: Blood
Blood (2009) 114 (22): 4821.
https://doi.org/10.1182/blood.V114.22.4821.4821
Published: 2009
Journal Articles

Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids.

Free
Ke Xu, MD, Aristotelis Antonopoulos, PhD, Emmanouil Spanoudakis, MD, PhD, Simon Parry, PhD, Aristeidis Chaidos, MD, PhD, Ming Hu, PhD, Terry Butters, PhD, Anne Dell, PhD, Amin Rahemtulla, MBBS, PhD, FRCP, Nikki Horwood, PhD, Anastasios Karadimitris, PhD, MRCP, FRCPath
Journal: Blood
Blood (2009) 114 (22): 424.
https://doi.org/10.1182/blood.V114.22.424.424
Published: 2009
Journal Articles

Glucosylceramide Synthetase Inhibitors Sensitise B-CLL Cells to Cytotoxic Agents without Reversing P-gp Functional Activity.

Free
Gareth Gerrard, MSc, Terry D. Butters, PhD, Atul B. Mehta, MD, A. Victor Hoffbrand, DSc, Derryln Hughes, MD, Michael Burgess, MD, Kanagasabai Ganeshaguru, PhD
Journal: Blood
Blood (2004) 104 (11): 1181.
https://doi.org/10.1182/blood.V104.11.1181.1181
Published: 2004